share_log

8-K: Current report

8-K: Current report

8-K：重大事件
美股sec公告 ·  08/12 12:06
Moomoo AI 已提取核心信息
60 Degrees Pharmaceuticals, Inc., a pharmaceutical company specializing in infectious disease treatments, has announced the completion of a 1-for-12 reverse stock split of its common stock, effective August 12, 2024. The reverse stock split was approved by the company's stockholders on July 16, 2024, and the final ratio was determined by the Board of Directors on July 19, 2024. The split, which was filed with the Secretary of State of Delaware on July 30, 2024, is intended to comply with Nasdaq's minimum bid price requirement. The company's common stock will continue trading on the Nasdaq under the symbol 'SXTP' with a new CUSIP number. No fractional shares were issued; instead, fractional amounts were rounded up to the nearest whole share. The reverse stock split affects all stockholders uniformly and does not change their percentage equity interest in the company. Equity Stock Transfer, LLC will act as the agent for the reverse stock split, and stockholders do not need to take any action to receive post-split shares.
60 Degrees Pharmaceuticals, Inc., a pharmaceutical company specializing in infectious disease treatments, has announced the completion of a 1-for-12 reverse stock split of its common stock, effective August 12, 2024. The reverse stock split was approved by the company's stockholders on July 16, 2024, and the final ratio was determined by the Board of Directors on July 19, 2024. The split, which was filed with the Secretary of State of Delaware on July 30, 2024, is intended to comply with Nasdaq's minimum bid price requirement. The company's common stock will continue trading on the Nasdaq under the symbol 'SXTP' with a new CUSIP number. No fractional shares were issued; instead, fractional amounts were rounded up to the nearest whole share. The reverse stock split affects all stockholders uniformly and does not change their percentage equity interest in the company. Equity Stock Transfer, LLC will act as the agent for the reverse stock split, and stockholders do not need to take any action to receive post-split shares.
医药公司60 Degrees Pharmaceuticals，Inc.专门从事传染性疾病治疗，已宣布于2024年8月12日完成普通股的1股拆12股逆向股票拆分。该逆向股票拆分已于2024年7月16日获得公司股东的批准，最终比例由董事会于2024年7月19日确定。这次拆分已在2024年7月30日提交给特拉华州国务卿，旨在符合纳斯达克的最低买盘价格要求。公司的普通股将继续在纳斯达克以“SXTP”为代号进行交易，并配以新的CUSIP编号。不发行碎股，而是将碎股数值四舍五入至最接近的整股。逆向股票拆分对所有股东均产生一致影响，并不改变他们在公司中的股权比例。Equity Stock Transfer, LLC将充当逆向股票拆分的代理人，股东无需采取任何行动即可获得拆分后的股份。
医药公司60 Degrees Pharmaceuticals，Inc.专门从事传染性疾病治疗，已宣布于2024年8月12日完成普通股的1股拆12股逆向股票拆分。该逆向股票拆分已于2024年7月16日获得公司股东的批准，最终比例由董事会于2024年7月19日确定。这次拆分已在2024年7月30日提交给特拉华州国务卿，旨在符合纳斯达克的最低买盘价格要求。公司的普通股将继续在纳斯达克以“SXTP”为代号进行交易，并配以新的CUSIP编号。不发行碎股，而是将碎股数值四舍五入至最接近的整股。逆向股票拆分对所有股东均产生一致影响，并不改变他们在公司中的股权比例。Equity Stock Transfer, LLC将充当逆向股票拆分的代理人，股东无需采取任何行动即可获得拆分后的股份。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

独立文件3  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息